Based on the above results, it is speculated that Notch1 gene might play a key role in glioma TMZ resistance, while ARV‐825 could degrade BRD4 protein to reverse glioma TMZ resistance by modulating Notch1 pathway related genes expression. The gene discussed is NOTCH1; the disease is central nervous system cancer.